Teva Pharmaceutical Industries (NYSE:TEVA) reported first-quarter 2026 results that management said reflect continued ...
Teva Pharmaceutical Industries (NYSE:TEVA) reported first-quarter 2026 results that management said reflected continued ...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Eric Hughes, Teva's EVP of Global R&D & Chief Medical Officer, will present at the BofA Securities Health Care Conference ...
Teva Pharmaceuticals CEO Richard Francis joins 'Money Movers' to discuss the company's latest acquisition of Emalex Biosciences, their latest drug offerings, and more.
Teva Pharmaceutical Industries (NYSE: TEVA) will unveil its first-quarter results this Wednesday, April 29. Many Teva ...
April 29 (Reuters) - Teva Pharmaceutical Industries beat Wall Street estimates for first-quarter profit on Wednesday, helped ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Stocks that Billionaire Druckenmiller and Jim Cramer like.
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced ...
April 29 () - Teva Pharmaceutical Industries beat Wall Street estimates for first-quarter profit on Wednesday, helped by ...
Teva Pharmaceuticals has struck a deal to buy Emalex Biosciences for $700 million | Teva Pharmaceuticals has struck a deal to ...
Teva (TEVA) stock jumps as the company exceeds forecasts with Q1 2026 financials. However, it cut its 2026 earnings outlook ...
Teva’s overall performance topped Wall Street estimates for Q1, according to Bloomberg News, which also pointed out that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results